Rewalk Robotics Ltd
NASDAQ:RWLK
Relative Value
There is not enough data to reliably calculate the relative value of RWLK.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
RWLK Competitors Multiples
Rewalk Robotics Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
IL |
Rewalk Robotics Ltd
NASDAQ:RWLK
|
57.9m USD | 6.3 | -2.7 | -1.2 | -1.1 | ||
US |
Abbott Laboratories
NYSE:ABT
|
184.7B USD | 4.6 | 32.8 | 19.4 | 28.9 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.1B USD | 18.8 | 69.1 | 56.6 | 71 | ||
US |
Stryker Corp
NYSE:SYK
|
126B USD | 6 | 37.4 | 24.4 | 30 | ||
IE |
Medtronic PLC
NYSE:MDT
|
109.1B USD | 3.4 | 26 | 13.8 | 19.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
107.6B USD | 7.3 | 60.9 | 30.6 | 45.4 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.8B USD | 3.5 | 56.6 | 18.8 | 39.8 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
57.5B EUR | 2.6 | 37.9 | 18.2 | 30.7 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
376.8B CNY | 11 | 33.2 | 29 | 29 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.5B USD | 13.5 | 80.6 | 60.2 | 78.4 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.6B USD | 8.4 | 36.5 | 26.5 | 28.7 |